Skip to content

Drug interactions

Lenacapavir + Roflumilast

Severity: Moderate

Lenacapavir and Roflumilast: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor, and the effect can persist for months after subcutaneous dosing. Roflumilast exposure may therefore rise, increasing PDE4-related adverse effects.

What this interaction means in plain words

Lenacapavir and Roflumilast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lenacapavir belongs to Anti Virals; Roflumilast belongs to Respiratory.

Evidence level: Low

Why it happens

Lenacapavir inhibits CYP3A4, decreasing roflumilast metabolism.

What to do

Monitor for diarrhea, weight loss, insomnia and mood changes, including when roflumilast is started months after the last lenacapavir injection. Consider stopping roflumilast if it is not tolerated.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenacapavir and Roflumilast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lenacapavir with Roflumilast?

MediHelp rates the interaction as moderate. Lenacapavir and Roflumilast can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A inhibitor, and the effect can persist for months after subcutaneous dosing. Roflumilast exposure may therefore rise, increasing PDE4-related adverse effects.

How serious is the interaction between Lenacapavir and Roflumilast?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for diarrhea, weight loss, insomnia and mood changes, including when roflumilast is started months after the last lenacapavir injection. Consider stopping roflumilast if it is not tolerated.

What other medicines interact with Roflumilast?

MediHelp also lists interactions of Roflumilast with, for example, Apalutamide, Carbamazepine, Efavirenz. The full list is on the Roflumilast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in